Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cell surface localized membrane type 1-matrix metalloproteinase (MT1-MMP) plays an important role in physiological and pathological processes and its function can be regulated by proteins such as RECK. We examined the ability of miR-182 (one of the miR-183 cluster miRNAs), which can target RECK, to control cell surface MT1-
MMP
activity. Expression of RECK mRNA and protein was increased with anti-miRs to miR-182, miR-183 or miR-96 in HT1080 fibrosarcoma cells, but, decreased RECK mRNA and increased its protein in the benign prostatic hyperplasia cell line BPH-1. Treatment of BPH-1 and
HT-1080
cells with the anti-miRs did not change the level of cell surface MT1-
MMP
activity, nor their rate of migration in an in vitro wound-healing assay. Trichostatin A (TSA) did not increase the level of RECK, but blocked cell surface MT1-
MMP
activity and decreased cell motility. Anti-miRs mediated increased RECK levels did not interfere with cell surface MT1-
MMP
function, and TSA may block cell surface localization of MT1-
MMP
by a mechanism independent of RECK.
...
PMID:MicroRNA miR-182 cluster mediated modulation of RECK without changes in cell surface membrane type-1 matrix metalloproteinase (MT1-MMP). 2660 96
During amoeboidal migration, cancer cells migrate in a protease-independent manner by squeezing through pre-existing gaps in the extracellular matrix (ECM). However, the extent to which cells alter their physical properties in order to sustain this mode of migration remains unclear. Here, we address this question by documenting biophysical changes in the properties of highly invasive MDA-MB-231 and
HT-1080
cells upon inhibition of pericellular proteolysis. Remarkably, treatment with the broad spectrum
MMP
inhibitor GM6001 not only induces cell rounding and loss of actomyosin contractility, but also induces nuclear softening via increased phosphorylation of the nuclear membrane protein lamin A/C. Though nuclear softening is necessary for sustaining migration through sub-nuclear sized transwell pores, it is not sufficient. In addition, baseline levels of contractility mediating pore entry and peri-nuclear actin inside the pores mediating pore migration are also required. Taken together, our results suggest that protease-independent migration through sub-nuclear sized pre-existing tracks is enabled by deformation of a softened nucleus by contractility and the peri-nuclear actin network.
...
PMID:Nuclear softening is essential for protease-independent migration. 3064 Nov 37
The current study investigated the ability of two secoiridoids, GL-3 (
1
) and oleonuezhenide (
2
), isolated from the fruits of
Ligustrum japonicum
to inhibit MMP-2 and -9 activity in phorbol 12-myristate 13-acetate (PMA)-induced
HT-1080
human fibrosarcoma cells. Both compound
s
1
and
2
were able to exert lowered gelatin digestion activity for MMP-2 and -9 tested by gelatin zymography via suppressing the release of MMPs to culture medium according to ELISA results. Treatment with compounds was also able to suppress the expression of both mRNA and protein levels of MMP-2 and -9. Action mechanism behind the
MMP
inhibitory effect of the compounds was suggested to be via MAPK pathway indicated by decreased levels of phosphorylated p38, ERK and JNK proteins evaluated employing immunoblotting. Compound
1
was shown to be slightly more active to inhibit MMP-2 and -9, however, compound
2
showed more regular dose-dependency during inhibition. In conclusion, this study suggested that GL-3 and oleonuezhenide were notable natural origin potent
MMP
inhibitors and could serve as lead compounds for development of anti-invasive
MMP
inhibitors against tumor metastasis.
...
PMID:Evaluation of MMP Inhibitors Isolated from
Ligustrum japonicum
Fructus. 3074 75
<< Previous
1
2
3
4